BioLife Solutions BLFS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $1.95M-13.7% | $2.25M-23.1% | $2.93M-20.8% | $3.7M-17.4% | $4.48M-13.2% | ||
| $23.65M+2.8% | $22.99M-13.6% | $26.61M+2.2% | $26.03M-9.9% | $28.89M-6.6% | ||
| $68K+4.6% | $65K— | —— | —— | —— | ||
| $4.84M+1,934% | -$264K-109% | $2.91M+36.8% | $2.13M-33.0% | $3.17M+2.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.15M+4,338% | ||
| —— | —— | —— | —— | —— | ||
| $274K+3.8% | $264K— | —— | —— | —— | ||
| -$1.83M+8.9% | -$2.01M-183% | -$709K+41.4% | -$1.21M+8.3% | -$1.32M-35.7% | ||
| $17.9M-11.0% | $20.12M+19.4% | $16.84M+8.4% | $15.54M+6.2% | $14.63M+73.6% | ||
| $9.56M-0.1% | $9.56M+161% | $3.67M+10.9% | $3.31M-7.7% | $3.58M+4.3% | ||
| $104.17M-8.7% | $114.06M+42.9% | $79.79M+10.8% | $72.01M+70.0% | $42.37M+130% | ||
| $8.59M+25.7% | $6.83M+51.8% | $4.5M+29.2% | $3.48M+11.7% | $3.12M-11.4% | ||
| —— | $23.52M-34.7% | $35.99M-25.7% | $48.47M-20.5% | $60.95M-17.0% | ||
| —— | $0-100% | $75K-50.0% | $150K-33.3% | $225K-25.0% | ||
| -$47.33M+34.9% | -$72.68M-7,663% | $961K-81.7% | $5.25M-83.3% | $31.35M-46.2% | ||
| $190K— | $0+100% | -$119K-63.0% | -$73K— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $26K-21.2% | $33K+214% | -$29K— | —— | —— | ||
| -$15.83M-44.9% | -$10.92M+12.7% | -$12.51M-13.8% | -$11M-24.6% | -$8.82M-30.1% | ||
| -$47.68M+27.7% | -$65.91M-1,346% | $5.29M-46.0% | $9.79M-73.6% | $37.16M-38.0% | ||
| $570K-25.2% | $762K-25.0% | $1.02M-19.3% | $1.26M-11.8% | $1.43M-11.2% | ||
| $753K+2.3% | $736K+22.3% | $602K+30.6% | $461K+16.1% | $397K-16.2% | ||
| $2.06M-15.5% | $2.43M-15.4% | $2.88M-6.8% | $3.09M-6.1% | $3.29M-6.1% | ||
| -$323K+36.7% | -$510K+17.6% | -$619K-7.7% | -$575K-3.4% | -$556K+1.9% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $10.32M-11.9% | $11.71M-10.6% | $13.1M-9.6% | $14.49M-8.7% | ||
| —— | —— | —— | —— | —— | ||
| -$1.83M+8.9% | -$2.01M-183% | -$709K+41.4% | -$1.21M+8.3% | -$1.32M-35.7% | ||
| $2K-99.9% | $3.04M-53.2% | $6.5M+32.5% | $4.9M+6.2% | $4.62M+91.9% | ||
| —— | $1.88M+24.0% | $1.51M+31.6% | $1.15M+46.1% | $786.75K+85.6% | ||
| —— | —— | —— | —— | —— | ||
| $48.2M+38.6% | $34.76M+56.9% | $22.15M+42.5% | $15.54M+0.9% | $15.4M-16.3% | ||
| $636K-28.2% | $886K+7.4% | $825K-6.9% | $886K-52.2% | $1.85M-10.3% | ||
| —— | $0-100% | $75K-50.0% | $150K-33.3% | $225K-25.0% | ||
| $8.59M+25.7% | $6.83M+51.8% | $4.5M+29.2% | $3.48M+11.7% | $3.12M-11.4% | ||
| $26K-21.2% | $33K+214% | -$29K— | —— | —— | ||
| $473K-51.5% | $975K-40.6% | $1.64M-20.2% | $2.06M-5.2% | $2.17M-9.4% | ||
| $10M0.0% | $10M0.0% | $10M0.0% | $10M+33.3% | $7.5M+50.0% | ||
| -$494K— | $0-100% | $460K— | —— | —— | ||
| -$135K-225% | $108K— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioLife Solutions generate?
- BioLife Solutions (BLFS) generated $17.9M in operating cash flow over the trailing twelve months.
- What is BioLife Solutions's free cash flow?
- After $9.6M of capital expenditures, BioLife Solutions's free cash flow was $14.1M over the trailing twelve months, up 110.7% year over year.
- Where does BioLife Solutions's cash flow data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
